Online citations, reference lists, and bibliographies.

Degradation Of Recombinant Proteins By Chinese Hamster Ovary Host Cell Proteases Is Prevented By Matriptase-1 Knockout.

Holger Laux, Sandrine Romand, Sandro Nuciforo, Christopher J. Farady, Joel Tapparel, Stine Buechmann-Moeller, Benjamin Patrick Sommer, Edward J. Oakeley, Ursula Bodendorf
Published 2018 · Chemistry, Medicine
Cite This
Download PDF
Analyze on Scholarcy
An increasing number of nonantibody format proteins are entering clinical development. However, one of the major hurdles for the production of nonantibody glycoproteins is host cell-related proteolytic degradation, which can drastically impact developability and timelines of pipeline projects. Chinese hamster ovary (CHO) cells are the preferred production host for recombinant therapeutic proteins. Using protease inhibitors, transcriptomics, and genetic knockdowns, we have identified, out of the >700 known proteases in rodents, matriptase-1 as the major protease involved in the degradation of recombinant proteins expressed in CHO-K1 cells. Subsequently, matriptase-1 was deleted in CHO-K1 cells using "transcription activator-like effector nucleases" (TALENs) as well as zinc-finger nucleases (ZFNs). This resulted in a superior CHO-K1 matriptase (KO) cell line with strongly reduced or no proteolytic degradation activity toward a panel of recombinantly expressed proteins. The matriptase KO cell line was evaluated in spike-in experiments and showed little or no degradation of proteins incubated in culture supernatant derived from the KO cells. This effect was confirmed when the same proteins were recombinantly expressed in the KO cell line. In summary, the combination of novel cell line engineering tools, next-generation sequencing screening methods, and the recently published Chinese hamster genome has enabled the development of this novel matriptase KO CHO cell line capable of improving expression yields of intact therapeutic proteins.
This paper references
Microchip assays for screening monoclonal antibody product quality.
Xiaoyu Chen (2008)
Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity.
Sharon X Gao (2011)
The Genomic Sequence of the Chinese Hamster Ovary (CHO) K1 cell line
Xun Xu (2011)
Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings (2016)
Targeted gene knockout by direct delivery of ZFN proteins
Thomas Gaj (2012)
Serine peptidases: Classification, structure and function
Martin John Page (2008)
Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium
Karen Hansen (1997)
Recombinant interferon-γ secreted by chinese hamster ovary-320 cells cultivated in suspension in protein-free media is protected against extracellular proteolysis by the expression of natural protease inhibitors and by the addition of plant protein hydrolysates to the culture medium
J. Mols (2007)
CRISPR-Cas9 mediated gene knockout in primary human airway epithelial cells reveals a pro-inflammatory role for MUC18
H. Chu (2015)
Chinese hamster genome sequenced from sorted chromosomes.
Karina Brinkrolf (2013)
Enhanced erythropoietin heterogeneity in a CHO culture is caused by proteolytic degradation and can be eliminated by a high glutamine level
Moon-sik Yang (2000)
Degradation of an Fc-fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D protease.
Flavie Robert (2009)
Chemical caspase inhibitors enhance cell culture viabilities and protein titer.
Nilou Arden (2007)
Protease expression in the supernatant of Chinese Hamster Ovary cells grown in serum-free culture
Peter Elliott (2004)
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis
Karin List (2002)
Cleavage of the transferrin receptor is influenced by the composition of the O-linked carbohydrate at position 104.
Elizabeth A. Rutledge (1996)
Monitoring proteolysis of recombinant human interferon-γ during batch culture of Chinese hamster ovary cells
M. H. Goldman (1997)
Mapping and partial characterization of proteases expressed by a CHO production cell line.
Helena Sandberg (2006)
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
Shih-Chin Cheng (2016)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Lê Chí Công (2013)
Suppression of the degradation of recombinant human apolipoprotein E by a protease inhibitor obtained from fetal bovine serum in serum-free culture
Takeshi Shimomura (1991)
CHO cells in biotechnology for production of recombinant proteins: current state and further potential
Jee Yon Kim (2011)
Biopharmaceutical benchmarks 2014
Gary Walsh (2014)
Matriptase: Potent Proteolysis on the Cell Surface
Karin List (2006)
Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells
Sundar Durai (2005)
The art of CHO cell engineering: A comprehensive retrospect and future perspectives.
Simon Fischer (2015)
Improving expression of recombinant human IGF-1 using IGF-1R knockout CHO cell lines.
Sandrine Romand (2016)
Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization
Sanjukta Chakrabarti (2016)
Characterization of the proteases involved in the N-terminal clipping of glucagon-like-peptide-1-antibody fusion proteins.
Haimanti Dorai (2011)
Fam60A plays a role for production stabilities of recombinant CHO cell lines.
Anett Ritter (2017)
Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome.
Nathan E. Lewis (2013)
Development of mammalian production cell lines expressing CNTO736, a glucagon like peptide-1-MIMETIBODY: factors that influence productivity and product quality.
Haimanti Dorai (2009)
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
M. Jinek (2012)
The Transmembrane Serine Protease Matriptase: Implications for Cellular Biology and Human Diseases
Yawen Chen (2012)
Deletion of a telomeric region on chromosome 8 correlates with higher productivity and stability of CHO cell lines.
Anett Ritter (2016)
Production of recombinant protein therapeutics in cultivated mammalian cells
F. M. Wurm (2004)
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.
Christopher J. Farady (2008)
Membrane-Anchored Serine Proteases in Health and Disease
Toni M Antalis (2011)
Disruption of the gene C12orf35 leads to increased productivities in recombinant CHO cell lines.
Anett Ritter (2016)
Mammalian cell protein expression for biopharmaceutical production.
Jianwei Zhu (2012)
Membrane-anchored serine proteases in vertebrate cell and developmental biology.
Roman Szabo (2011)
Modeling studies of the change in conformation required for cleavage of limited proteolytic sites.
Simon J. Hubbard (1994)
Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes
Ting Li (2011)
Genetic engineering of human ES and iPS cells using TALE nucleases
Dirk Hockemeyer (2011)
TALEs of genome targeting
Jens Boch (2011)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar